Wikisage, the free encyclopedia of the second generation, is digital heritage
Iscador: Difference between revisions
Jump to navigation
Jump to search
(rfz4) |
No edit summary |
||
| (11 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Mistletoe (Iskador mali) a preparation of Viscum album [[Carl von Linné|L.]]) off-label. Since decades Mistletoe has been used in European medicine for oncology<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052504/ Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study] </ref>Mistletoe lectins (e.g. Iscador Q [[viscotoxin]]) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485514/ Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas]</ref> | Mistletoe (Iskador mali) a preparation of [[Viscum album]] [[Carl von Linné|L.]]) off-label. Since decades Mistletoe has been used in European medicine for oncology<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052504/ Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study] </ref>Mistletoe lectins (e.g. Iscador Q [[viscotoxin]]) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485514/ Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas]</ref> | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133960/ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients] | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133960/ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients] | ||
</ref> | </ref> | ||
Büssing et Ostermann (2012<ref> [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124023/ Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis]</ref>) found some evidence for moderate improvement of quality of life associated with Iscador treatment (Weleda<ref>[https://www.iscador.com/assets/uploads/files/Newsletter_Sommer_2015.pdf Iscador Newsletter summer 2015]</ref>). | |||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086310/ Quality of Life and Neutropenia in Patients with Early Stage Breast Cancer: A Randomized Pilot Study Comparing Additional Treatment with Mistletoe Extract to Chemotherapy Alone]</ref> | |||
Pine mistletoe extract (Iscador P Viscum album austriacus) can be used on equine sarcoids as safe and effective treatment.<ref> [http://onlinelibrary.wiley.com/doi/10.1111/j.1939-1676.2010.0597.x/epdf Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus)]</ref> | |||
< | <ref>[http://www.ncbi.nlm.nih.gov/pubmed/18955241 Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?]</ref> | ||
==Links == | |||
*[http://www.pharmawiki.ch/wiki/index.php?wiki=Anthroposophischer%20Mistelextrakt Pharmawiki(de):Mistelextrakt] | |||
*[http://www.whocc.no/atc_ddd_index/?code=L01CZ ATC:L01CZ] | |||
==References== | |||
{{refs}} | |||
Latest revision as of 23:28, 2 September 2021
Mistletoe (Iskador mali) a preparation of Viscum album L.) off-label. Since decades Mistletoe has been used in European medicine for oncology[1]Mistletoe lectins (e.g. Iscador Q viscotoxin) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity[2] [3]
Büssing et Ostermann (2012[4]) found some evidence for moderate improvement of quality of life associated with Iscador treatment (Weleda[5]). [6] Pine mistletoe extract (Iscador P Viscum album austriacus) can be used on equine sarcoids as safe and effective treatment.[7]